Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs dexmedetomidine vs ondansetron for prevention of postoperative nausea and vomiting after laparotomic hysterectomy
IRCT20170516033992N15Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of dexamethasone, dexmedetomidine and ondansetron in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Frequency of nausea and vomiting and Severity of nausea and vomiting. Started Nov 2024; status: completed.
02
Drugs
dexamethasonedexmedetomidineondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20170516033992N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170516033992N15.